News and Announcements
Want to be the first to hear about NU GoKidney updates, events, & resources? Join our mailing list.
We are happy to announce the grants awarded from our recent call for proposals for our FY2022 NUGoKidney Pilot & Feasibility (P&F) Program. Of the many innovative, high-quality proposals we received, we were able to fund three new projects and renew one project for a second year, totaling nearly $150,000 in funds.
The kidney has largely been overlooked as a target organ for nanoparticle‑mediated drug delivery. On July 14, 2021, participants explored nephrotherapeutics development using nanotechnologies with Evan Scott, PhD, NUGoKidney Therapeutic Design and Development Core co-director. Dr. Scott discussed his ongoing work developing rationally designed nanomaterials for controlled targeted therapeutic delivery and potential applications to kidney therapeutics. Pinelopi Kapistsinou, MD , Core co-director moderated the webinar.
Watch the webinar video recording here.
Evan and his lab are working to collaborate with scientists of different disciplines on nano-therapeutics. Request a consultation to learn more about how you can use nanocarriers in your research.
Two time Pilot and Feasibility awardee, Jennie J Lin, MD, MTR has been announced American Society of Nephrology (ASN) 2021 Carl W. Gottschalk Research Scholar Grant recipient. The awarded project titled, Endoplasmic Reticulum Stress and Macrophage Function in APOL1 Nephropathy, studies how genetic variants modulate macrophage function at the intersection of kidney and cardiovascular disease.
Learn more about Dr. Lin and her projects: https://www.kidneycure.org/pages/qa.aspx?ID=37
NUGoKidney is excited to welcome its third cohort of scholars into the SciHigh Summer Program. In this summer’s program, 13 students from local Chicago high schools will work with mentors from Northwestern and Loyola on kidney research while gaining exposure to topics and experts in other fields such as pediatrics, genetics, nanoscience, data science, and artificial intelligence. Along with building their fluency in scientific processes, students will participate in a series of professional skills development workshops on project management, time management, networking, and interviewing.
Read about our welcome event and program plan here.
- Northwestern Health Equity Week brings session focused on Kidney Health Equity moderated by NUGoKidney Director06.18.2021
NUGoKidney Director, Susan Quaggin, MD partnered with Feinberg Minority Faculty Association with support from NUCATS to moderate a discussion around racial inequity in kidney care and transplant. During the Kidney Health Equity session, speaker Dinee Simpson, MD addressed the racial biases that impact chances of receiving a kidney transplant. While guest speaker, attending nephrologist and Assistant Professor of Medicine at the University of Pennsylvania, Nwamaka Eneanya, MD, MPH, discussed the inaccuracies in estimated glomerular filtration rate (eGFR), a measurement of kidney function. Ray Bignall, MD, FAAP, FASN, director of Kidney Health Advocacy and Community Engagement at Nationwide Children’s Hospital, rounded out the discussion with an inspiring talk on advocacy in medicine and nephrology, inviting participants to find what helps our “purpose meet [our] passion.”
Watch the recorded session on Kidney Health Equity here (available until August 25, 2021, NetID credentials required).
Find recordings for all Healthy Equity sessions here.
Read the full recap of Health Equity Week here.
NUGoKidney and partners, Melvin Thompson, executive director at The Endeleo Institute and Dinee Simpson, MD, founder of Northwestern Medicine African American Transplant Access Program (AATAP) were one of 21 recipients of Northwestern University's Racial Equity & Community Partnership Grants. The awarded proposal aims to help advance racial equity and address kidney health disparities in communities. Specifically, minimizing the barrier between African Americans and organ transplants by creating access to healthy foods.
NUGoKidney initially partnered with The Endeleo Institute and Dinee Simpson, MD in 2019, thanks to the seeds grant from the Center for Community Health (CCH) Alliance for Research in Chicago Communities (ARCC).
Read more about the funded proposal and other awardees here.
Pinelopi Kapitsinou, MD, co-director of NUGoKidney's Therapeutic Design & Development Core (Core B), and Dan Batlle, MD, NUGoKidney Core B user, recently received NUCATS COVID-19 Collaborative Innovation Awards, which funds new interdisciplinary research and collaboration. Pinelopi Kapitsinou, MD combines expertise in acute kidney injury epidemiology with systems biology knowledge while Dan Batlle, MD pursues the identification of a plasma factor that inhibits binding of SARS-CoV-2 to its host receptor, Angiotensin Converting Enzyme 2 (ACE2).
Read more about NUCATS COVID-19 Collaborative Innovation Award here.
Northwestern’s George M. O’Brien Kidney Research Core Center (NU GoKidney) is joining with other O’Brien Kidney Centers for the National O’Brien Centers Kidney Seminars (NOCKS).
On Friday, March 12th from 11am - 12pm join us for our co-hosted NOCKS featuring Evan Scott, PhD who will discuss his ongoing work of developing rationally designed nanomaterials for controlled targeted therapeutic delivery and potential applications to kidney therapeutics.
NUGoKidney’s SciHigh Program recently joined forces with local non-profit – Color of MedicineTM – to put on a virtual science lab for elementary school students. The first virtual lab kicked off on February 19, 2021 with 3rd grade students from Park Manor Elementary School.
After learning about their mutually shared missions of promoting inclusion of students from underrepresented backgrounds in STEM and medicine, Color of MedicineTM and SciHigh decided to collaborate to bring the magic of science to students through virtual science labs.
Last year on World Kidney Day, we reached nearly 350,000 people with our #sockittokidneydisease campaign, and we're doing it again this year to amplify the World Kidney Day 2021 message on symptom management and patient empowerment so patients with kidney disease can live well and fully participate in every-day life.
Ready your socks and learn how you can sock it to kidney disease.
NUGoKidney's Director - Susan Quaggin, MD, - to lead the American Society of Nephrology in 2021.
During her term as president, the society will focus specifically on eliminating kidney health disparities that will include launching new programs such as the loan mitigation program for trainees underrepresented in medicine, ensuring implementation and access to life- and kidney-saving new therapies such as SGLT2 inhibitors, and harnessing all the transformative advances in the specialty to redefine kidney medicine.
Read the full story here.
Co-director of NUGoKidney's Therapeutic Design & Development Core - Pinelopi Kapitsinou, MD - talks about her work examining the molecular mechanisms by which hypoxic signaling modulates responses to acute kidney injury and how findings in the lab translate to novel diagnostic and therapeutic approaches.
Tamara Isakova, MD, MMSc, director of NUGoKidney's Clinical & Translational Core and the Margaret Gray Morton Professor of Medicine, has been named co-director of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute’s KL2 Program, which supports early-career faculty at Northwestern.
Read more about Isakova's vision for the program here.
On November 19, 2020, we lost a treasure of a human being, H. William Schnaper, MD. An exemplary scientist, Bill contributed greatly to the understanding of childhood glomerulonephritis, as well as factors that contribute to renal fibrosis. But Bill’s love for science and medicine didn’t stop at the lab or the clinic. Unceasingly giving and committed, Bill shared his enthusiasm for science and dedication to mentorship in programs he developed for high school and medical students. As director for NUGoKidney’s Enrichment Program, Bill led the creation of the SciHigh Program, which aims to spark students’ curiosity and develop their confidence and skills to achieve success in science and medicine. Personally and professionally, Bill touched the lives of many with his brilliant scientific mind, generous spirit, and compassion for patients - someone so special can never be forgotten.Read Northwestern’s tribute to Bill here.
While we'll miss seeing our kidney colleagues and community in-person this year, we're excited to connect with you virtually in this year of reimagination!
We have over 50 presentations, sessions, and posters showcasing research from NUGoKidney and Northwestern researchers.
Experts from our Therapeutic Design and Development Core were joined by infectious disease and organ transplant expert, Michael Ison, MD, MS and nephrologist and kidney researcher, Anand Srivastava, MD, MPH to discuss about the impact of COVID-19 on the kidneys; recent research efforts; and therapeutic development opportunities.
Gal Finer, MD, PhD, Assistant Professor of Pediatrics in the Division of Kidney Diseases at Lurie Children’s recently received a 5-year K08 award from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to study the molecular mechanisms underlying congenital anomalies of the kidney and urinary tract, or CAKUT – a common birth defect and the leading cause of chronic kidney disease in children.
We are happy to announce the grants awarded from our recent call for proposals for our FY2021 NUGoKidney Pilot & Feasibility (P&F) Program.
- Webinar Recording Now Available: ACE2 Before and After COVID-19: Basic Concepts with Daniel Batlle, MD07.01.2020What is the link between COVID19 and ACE2? Get the answer in this recording from our June 18, 2020 webinar with Daniel Batlle, MD where he discusses ACE2, the renin angiotensin system, and COVID-19.
Click here to view a recording of the webinar.
2018 NUGoKidney Pilot & Feasibility Grant Awardee - Paul DeCaen, PhD - publishes study uncovering the molecular mechanisms behind the development of autosomal dominant polycystic kidney disease (ADPKD), a common genetic disorder characterized by the growth of numerous cysts in the kidneys.
Read more about the study in FSM News here.
Read the publication in Proceedings of the National Academy of Sciences here.
NUGoKidney Pilot & Feasibility awardee, Anand Srivastava, MD, MPH, recently received a five-year K23 award from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK). The study aims to examine whether information about kidney blood flow obtained from contrast enhanced ultrasound (CEUS) will help identify patients with chronic kidney disease (CKD) who are at high risk of experiencing progressive loss of kidney function.
On April 29, 2020, NUGoKidney presented the webinar - CRRT for AKI during the COVID-19 Pandemic - with special guest, Ashita Tolwani, MD from the University of Alabama at Birmingham (UAB).
Dr. Tolwani explained how CRRT prescription might need to be adjusted in regards to modality, dose, and anticoagulation for AKI patients with COVID-19.
Click here to view a recording of the webinar.
Studied by Jing Jin, MD, PhD and his team as a therapy for acute kidney injury (AKI) and hypertension, ACE2-fc, was recently included in an article by Robert Kruse, MD, PhD in F100 Research as a potential therapy for COVID-19.
Dr. Jin talks with NM Better Edge podcast about how the ACE2-fc therapy could potentially be used to guard against and treat COVID-19 and highlights the important role of cross collaboration in facilitating discovery. Listen now here.
Over 70 high school juniors from Holy Trinity High School participated in the SciHigh workshop - Data IRL: Thinking Big & Improving Health - focused on real-world uses of data and computing in medicine and health research.
Last year on World Kidney Day, we reached nearly 400,000 people with our #sockittokidneydisease campaign, and we're doing it again this year to amplify the World Kidney Day 2020 message on the importance of preventive interventions to avert the onset and progression of kidney disease.
Ready your socks and learn how you can sock it to kidney disease.
2019 was an incredible year for advancing kidney health and NUGoKidney. Take a look back with us as we reflect on some of our favorite moments and achievements from the past year.
NUGoKidney Director, Susan Quaggin, was recently selected as one of Crain's Most Notable Women in Health Care. In its second year, the prestigious honor spotlights the impressive and influential women leaders that have made an impact for both patients and health care workers in Chicago's health care community.
Honorees included other exceptional leaders from the Feinberg School of Medicine including Connie Falcone, JD, MBA; Amy Paller, MD; Diane Wayne, MD; Anna Shannahan, MD; Michelle Stephenson, DNP, RN, NEA-BC; Teresa Woodruff, PhD; and Joanne C. Smith, MD.
ASN's Kidney Week 2019 is finally here! We have over 60 presentations, sessions, and posters showcasing research from NUGoKidney and Northwestern researchers.
On Friday, October, 18th, NUGoKidney held its first ever Kidney Disease Therapeutic Innovation Symposium entitled, The Revolution in Kidney Medicine: Creating a World Beyond Kidney Disease.
Over 100 attendees joined the day of expert-led presentations, lightning talks, poster competition, and networking session. The event provided NUGoKidney and the kidney research community with opportunities to build expertise and forge new collaborations for advancing therapeutic discovery and implementation in kidney diseases.